Impact of Preemptive Analgesia on Recovery From Surgery

超前镇痛对手术恢复的影响

基本信息

  • 批准号:
    6351996
  • 负责人:
  • 金额:
    $ 35.9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-30 至 2001-12-21
  • 项目状态:
    已结题

项目摘要

Pain, often severe and inadequately treated, accompanies the more than 23 million surgical procedures performed annually in the U,S. Almost 2/3 of patients cite postoperative pain as their major preoperative fear. Apart from the mounting evidence that pain interferes with physiologic functions such as breathing, blood pressure regulation, etc., the pain associated with surgery limits the ability of patients to care for themselves, can be prolonged, may lead to chronic pain syndromes, and could possibly influence a patient's decision to delay or postpone potentially lifesaving surgery. Recent evidence indicates that residual pain following major surgery is more common than first appreciated, and that this pain is associated with significant decreases in functionality and self-perception of health. Painful stimuli initiate a cascade of responses which sensitize the nervous system so that subsequent painful stimuli are perceived with greater intensity and even typically painless stimuli can elicit pain. Preemptive analgesia is an intervention designed to prevent the sensitization of the nervous system produced by painful stimuli by beginning the analgesic regimen before the onset of pain stimuli. There is a definitive body of laboratory evidence and a growing body of clinical evidence that preemptive analgesia can reduce pain and analgesic needs following surgery, and our recent research indicates that this benefit can be observed in humans long after discharge from the hospital in the form of increased activity and decreased residual pain. One of the most common and clinically effective preemptive analgesic regimens involves the use of an epidural catheter. Adequate doses of medications introduced into the epidural space before the start of surgery and continued into the postoperative period appear to limit sensitization of the nervous system despite adequate levels of general anesthesia. However, preemptive epidural analgesia requires additional physician and other resources before, during and after surgery, Consequently, such an intervention will be supported by individual practitioners and third-party payers only in the face of demonstrable efficacy. This application considers the short- and long-term costs and benefits of aggressive preemptive epidural analgesia in generally healthy adult patients undergoing a common major abdominal surgical procedure. Pain during hospitalization and after discharge, activity levels, nursing needs, and the return to normal function will be quantitatively and economically assessed. These results will quantify the role played by aggressive perioperative pain management, will further link reductions in perioperative pain and outcome, and by quantifying the impact of recovery from major surgery will permit more rational allocation of scarce healthcare resources to effective strategies for acute pain management.
在美国,每年有2300多万例外科手术伴随着疼痛,通常是严重的和没有得到充分治疗的。几乎三分之二的患者将术后疼痛作为他们术前的主要恐惧。除了越来越多的证据表明疼痛会干扰呼吸、血压调节等生理功能外,与手术相关的疼痛还会限制患者的自我照顾能力,可能会延长时间,可能会导致慢性疼痛综合征,并可能影响患者推迟或推迟可能挽救生命的手术的决定。最近的证据表明,大手术后的残余疼痛比最初意识到的更常见,这种疼痛与功能和自我健康意识的显著下降有关。疼痛刺激引发一系列反应,使神经系统变得敏感,从而使随后的疼痛刺激更强烈地被察觉,甚至典型的无痛刺激也会引起疼痛。超前镇痛是一种干预措施,旨在通过在疼痛刺激开始之前开始止痛方案来防止疼痛刺激引起的神经系统敏感化。有确凿的实验室证据和越来越多的临床证据表明,超前止痛可以减少手术后的疼痛和止痛药需求,我们最近的研究表明,在出院后很长一段时间内,人类都可以观察到这种好处,表现为活动增加和残余疼痛减少。最常见和临床有效的超前止痛方案之一涉及使用硬膜外导管。手术前进入硬膜外间隙并持续到术后的足够剂量的药物似乎限制了神经系统的敏感化,尽管全身麻醉水平足够。然而,超前硬膜外镇痛在手术前、术中和术后都需要额外的医生和其他资源,因此,只有在有明显疗效的情况下,这种干预才会得到个人从业者和第三方付款人的支持。这项应用考虑了在一般健康的成年患者中接受普通的腹部大手术的积极超前硬膜外止痛的短期和长期成本和好处。住院期间和出院后的疼痛、活动水平、护理需求以及恢复正常功能将进行定量和经济评估。这些结果将量化积极的围手术期疼痛管理所发挥的作用,将进一步将围手术期疼痛的减少和结果联系起来,并通过量化大手术恢复的影响,将允许将稀缺的医疗资源更合理地分配给急性疼痛管理的有效战略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALLAN GOTTSCHALK其他文献

ALLAN GOTTSCHALK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALLAN GOTTSCHALK', 18)}}的其他基金

VOLATILE ANESTHETIC ACTION IN A COMPUTATIONAL MODEL OF THALAMOCORTICAL NETWORKS
丘脑皮质网络计算模型中的挥发性麻醉作用
  • 批准号:
    8364228
  • 财政年份:
    2011
  • 资助金额:
    $ 35.9万
  • 项目类别:
VOLATILE ANESTHETIC ACTION IN A COMPUTATIONAL MODEL OF THALAMOCORTICAL NETWORKS
丘脑皮质网络计算模型中的挥发性麻醉作用
  • 批准号:
    8171810
  • 财政年份:
    2010
  • 资助金额:
    $ 35.9万
  • 项目类别:
COMPUTATIONAL ASPECTS OF VOLATILE ANESTHETIC ACTION AT THE THALAMUS
丘脑挥发性麻醉作用的计算方面
  • 批准号:
    7601332
  • 财政年份:
    2007
  • 资助金额:
    $ 35.9万
  • 项目类别:
Postdoctoral Research Training in Anesthesiology and Critical Care Medicine
麻醉学和重症监护医学博士后研究培训
  • 批准号:
    8291277
  • 财政年份:
    2006
  • 资助金额:
    $ 35.9万
  • 项目类别:
Postdoctoral Research Training in Anesthesiology and Critical Care Medicine
麻醉学和重症监护医学博士后研究培训
  • 批准号:
    8487417
  • 财政年份:
    2006
  • 资助金额:
    $ 35.9万
  • 项目类别:
Postdoctoral Research Training in Anesthesiology and Critical Care Medicine
麻醉学和重症监护医学博士后研究培训
  • 批准号:
    7008733
  • 财政年份:
    2006
  • 资助金额:
    $ 35.9万
  • 项目类别:
Postdoctoral Research Training in Anesthesiology and Critical Care Medicine
麻醉学和重症监护医学博士后研究培训
  • 批准号:
    8677599
  • 财政年份:
    2006
  • 资助金额:
    $ 35.9万
  • 项目类别:
Postdoctoral Research Training in Anesthesiology and Critical Care Medicine
麻醉学和重症监护医学博士后研究培训
  • 批准号:
    7250854
  • 财政年份:
    2006
  • 资助金额:
    $ 35.9万
  • 项目类别:
Postdoctoral Research Training in Anesthesiology and Critical Care Medicine
麻醉学和重症监护医学博士后研究培训
  • 批准号:
    7486259
  • 财政年份:
    2006
  • 资助金额:
    $ 35.9万
  • 项目类别:
Postdoctoral Research Training in Anesthesiology and Critical Care Medicine
麻醉学和重症监护医学博士后研究培训
  • 批准号:
    7882307
  • 财政年份:
    2006
  • 资助金额:
    $ 35.9万
  • 项目类别:

相似海外基金

Unravelling the neural basis of breathing, respiratory depression, and analgesia by opioid drugs.
揭示阿片类药物呼吸、呼吸抑制和镇痛的神经基础。
  • 批准号:
    479039
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
    Operating Grants
Dissociating respiratory depression and analgesia via a data-driven model of interacting respiratory and pain networks
通过呼吸和疼痛网络相互作用的数据驱动模型分离呼吸抑制和镇痛
  • 批准号:
    10644300
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
Elucidating causal mechanisms of ethanol-induced analgesia in BXD recombinant inbred mouse lines
阐明 BXD 重组近交系小鼠乙醇诱导镇痛的因果机制
  • 批准号:
    10825737
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
  • 批准号:
    10608439
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
Evaluation of the Role of Macrophage Migratory Inhibitory Factor (MIF) in mediating Stem Cell Analgesia in a Model of Orofacial Pain
评估巨噬细胞迁移抑制因子(MIF)在口面部疼痛模型中介导干细胞镇痛的作用
  • 批准号:
    10585412
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Study: A Pilot Randomized Controlled Trial
裸盖菇素用于增强慢性神经病性疼痛 (PEACE-PAIN) 镇痛效果的研究:一项随机对照试验
  • 批准号:
    479442
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
    Operating Grants
Development of a regional anesthesia guidance system to increase patient access to opioid-sparing analgesia for hip fracture pain
开发区域麻醉引导系统,以增加患者获得髋部骨折疼痛的阿片类药物保留镇痛的机会
  • 批准号:
    10759550
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
Maintaining opioid analgesia and preventing addiction with hypocretin antagonism
通过下丘脑分泌素拮抗作用维持阿片类药物镇痛并预防成瘾
  • 批准号:
    10713175
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
Disease Modifying Analgesia with CA8 Gene Therapy
CA8 基因治疗的疾病修饰镇痛
  • 批准号:
    10710264
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
Circuit mechanisms for opioid analgesia and addiction in prefrontal cortex
前额皮质阿片类镇痛和成瘾的回路机制
  • 批准号:
    10607118
  • 财政年份:
    2023
  • 资助金额:
    $ 35.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了